Short-Term Rituximab Treatment Effective Against ANCA VasculitisShort-Term Rituximab Treatment Effective Against ANCA Vasculitis

Four weeks of treatment with rituximab is as effective as 18 months of therapy with cyclophosphamide and azathioprine for people with severe antineutrophil cytoplasmic antibody-associated vasculitis. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news